tirzepatide for psoriatic arthritis 🚨 First-of-its-kind Phase 3b data: treating obesity improves outcomes Today, Eli Lilly and Company announced positive topline results from TOGETHER-PsA, the first controlled trial evaluating an incretin therapy used alongside tirzepatide arthritis New trial confirms
Pay in 4 interest-free payments of $6.91 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20



























